AGP Picks
View all

AGP Executive Report

Last update: 11 hours ago

EU Travel Rules: The EU’s Entry/Exit System (EES) is now fully operational, replacing passport stamps with a digital record of entries and exits plus facial images and fingerprints for eligible non-EU short-stay visitors (up to 90 days in 180). Public Health & Climate: July 2026 has tied with July 2024 as the hottest July on record, with NOAA and NASA reporting record heat—an ongoing reminder for heat-risk planning and health protection. Medicine & Weight Loss: Gan & Lee’s weight-loss drug Bofenglutide is moving into a wider European rollout as Menarini buys commercialization rights for overweight/obesity across EU and several partner countries, with down payments and milestone payments involved. Travel Safety (Passports): A UK travel advisory highlights strict passport validity rules for trips to EU countries and several European states, with at least three months left after departure and passports issued within the last 10 years. Local Relevance: Liechtenstein is explicitly named in the EES rollout context and in the Bofenglutide licensing region.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 2, 2026

American Swiss Foundation honors Adrian Keller at leadership dinner in Rüschlikon

AGP

fallback image
Jun. 24, 2026

Shufti, Evrotrust link identity checks to qualified signatures across EU onboarding

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand


fallback image
Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
Aug. 14, 2026

Obyte Introduces Coop: A Decentralized Community System to Reward Meaningful Contributions

EIN Presswire

fallback image
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

fallback image
May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

GlobeNewswire, Inc.

fallback image
May 18, 2026

New Memoranda pave the way for €50 million in investments in local development and public health

Government of Slovenia

More press releases

Video Stories

YouTube video thumbnail: Geography Now! Liechtenstein
Play
Geography Now! Liechtenstein
YouTube video thumbnail: Liechtenstein: Where Princes Reign Supreme
Play
Liechtenstein: Where Princes Reign Supreme
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How an Isolated Valley Became the World's Richest Country
Play
How an Isolated Valley Became the World's Richest Country
YouTube video thumbnail: Liechtenstein: Europe’s Last Absolute Monarchy
Play
Liechtenstein: Europe’s Last Absolute Monarchy

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.